# Task Order 1: The Interventional Agent Development Services Program

> **NIH NIH N01** · SRI INTERNATIONAL · 2022 · $82

## Abstract

The Interventional Agent Development Services program provides services to facilitate preclinical development of therapeutics and new in vivo diagnostics for infectious disease-causing pathogens and/or toxins, such as imaging and skin test reagents. Services include: lead identification and development; chemistry and manufacturing; in vitro and in vivo preclinical safety, toxicology and biokinetics; and preclinical development, planning and evaluation.

## Key facts

- **NIH application ID:** 10704965
- **Project number:** 272201100022I-P00017-27200001-1
- **Recipient organization:** SRI INTERNATIONAL
- **Principal Investigator:** JON MIRSALIS
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $82
- **Award type:** —
- **Project period:** 2018-09-05 → 2020-02-15

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10704965

## Citation

> US National Institutes of Health, RePORTER application 10704965, Task Order 1: The Interventional Agent Development Services Program (272201100022I-P00017-27200001-1). Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/grant/nih/10704965. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*